Tirzepatide (10 mg)

Description

Tirzepatide 10 mg is a dual GIP and GLP-1 receptor agonist. Tirzepatide works through two hormone pathways involved in glucose regulation and appetite-related signaling.

Tirzepatide is available as an FDA-approved prescription medicine for specific medical indications. Depending on the product and indication, it may be prescribed alongside a reduced-calorie diet and increased physical activity for eligible adults with obesity or overweight with certain weight-related conditions.

Treatment with tirzepatide should be determined and monitored by a qualified healthcare professional. The appropriate product, formulation, strength, and treatment plan depend on the individual patient’s medical circumstances.

Key Information

• Product: Tirzepatide
• Strength: 10 mg
• Drug class: GIP/GLP-1 receptor agonist
• Type: Prescription medication
• Administration: As directed by a qualified healthcare professional
• Use: Approved medical indications, depending on the specific approved product

Important: This product should not be used without appropriate medical supervision. If your product is compounded or otherwise not FDA-approved, do not describe it as FDA-approved or as equivalent to an FDA-approved product; compounded drugs are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality before marketing.